Signal 1 is a technology company.
Signal 1 has raised $10.0M across 1 funding round.
Signal 1 has raised $10.0M in total across 1 funding round.
Signal 1 has raised $10.0M in total across 1 funding round.
Signal 1's investors include Accomplice VC, Action Potential Venture Capital, iNovia Capital, Saltagen Ventures, Sandbox Industries, Frederic Kerrest.
Signal 1 is a Toronto-based health AI startup founded in April 2022 that builds a centralized AI management platform for health systems, enabling efficient deployment, monitoring, and governance of AI tools to transform patient care responsibly.[1][2][3][4] Its core product is the Signal Health AI Platform, which integrates AI-driven insights—like a clinically validated real-time patient risk predictor—into hospital workflows, serving hospitals and healthcare providers to improve care quality, operational flow, and frontline staff support while managing risks such as compliance and performance drift.[1][3][4] With $10M raised in a seed round from Inovia Capital, the company monitors over 1,000 beds across five major hospitals, including deployments co-developed with St. Michael’s Hospital, demonstrating strong early traction in North American healthcare.[1][3][4][5]
Signal 1 was co-founded in April 2022 in Toronto—"the birthplace of Deep Learning"—by a team of technology, business, and healthcare experts, led by CEO Tomi Poutanen, who previously co-founded Layer 6 (acquired by TD Bank, where he served as Chief AI Officer) and contributed to exits at Microsoft and Yahoo!, holding an MSc in Computer Engineering and MBA from the University of Toronto; he also co-founded the Vector Institute for AI.[4][5] VP Product Dan Shiner brings experience from co-founding an HR tech startup, leading AI products at Xero, and heading product at Hubdoc (acquired by Xero), with a JD/MBA from the University of Toronto.[5] The idea emerged from the team's prior work creating Responsible AI standards for financial services at TD Bank in 2019, adapting that technology to healthcare challenges like high AI adoption costs, regulatory hurdles, and slow deployment; early traction came from partnering with St. Michael’s Hospital, a top North American research institution, to validate and deploy applications across multiple hospitals.[3][4][5]
Signal 1 rides the AI-in-healthcare wave, addressing hype-to-value gaps amid surging demand for tools that cut costs, boost diagnostics, and personalize care—exemplified by peers like PathAI and Paige, but differentiated by its governance focus amid regulatory pressures (e.g., FDA scrutiny on AI/ML devices).[2][3][4] Timing is ideal post-2022 AI boom and Hinton's Nobel recognition, with market forces like hospital data silos, staffing shortages, and $10M+ investments favoring scalable platforms that integrate existing AI investments without rip-and-replace overhauls.[1][3] It influences the ecosystem by setting healthcare Responsible AI best practices, enabling faster global deployment of hospital-validated tools (e.g., from St. Michael’s), and bridging tech innovation with clinical needs in a $100B+ digital health market.[3][4][5]
Signal 1 is poised to expand its platform as health systems scale AI portfolios, potentially powering enterprise-wide deployments beyond patient risk prediction into diagnostics and operations. Trends like multimodal AI, stricter global regs (e.g., EU AI Act), and multimodal data integration will shape its path, amplifying its governance edge. Its influence may evolve from early adopter enabler to industry standard-setter, much like its financial services roots at TD Bank—tying back to its mission of turning AI hype into responsible, measurable patient care impact.[3][4][5]
Signal 1 has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Seed in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $10.0M Seed | Accomplice VC, Action Potential Venture Capital, iNovia Capital, Saltagen Ventures, Sandbox Industries, Frederic Kerrest |